Eagle Pharmaceuticals (EGRX) Tops Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Eagle Pharmaceuticals (EGRX) Tops Q2 EPS by 4c

Eagle Pharmaceuticals (EGRX) PT Raised to $120 at Piper Jaffray

August 12, 2015 8:28 AM EDT

Piper Jaffray analyst David Amsellem reiterated an Overweight rating and lifted his price target on Eagle Pharmaceuticals (NASDAQ: EGRX) to $120.00 (from $119.00) following the company's Q2 update.

commented, "This morning, Eagle reported net results per share of ($0.53) on revenues of $6M. Management provided... More